The Impact of a Natural Ingredients and App Based Intervention Targeting the Nine Hallmarks of Aging on DNA Methylation
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Biological age
研究概览
简要总结
SRW Laboratories has formulated the Cel System protocol, a group of three formulas designed to interact with each of the 9 Hallmarks of Aging and combined this with an App that supports positive lifestyle changes, with a view that, if we can positively impact each Hallmark, we can support healthy aging.
详细描述
This study will measure the impact of the Cel System protocol on the biological clocks of the participants, as well as measure established biomarkers associated with the 9 Hallmarks and note any aesthetic changes you may experience to establish evidence of the effect of the Cel System Protocol over time.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 55 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Men and women of any ethnicity
- •55 years and older
- •Female subjects must be post-menopausal
- •Participant must be able to comply with treatment plan and laboratory tests
- •Participant must be able to read, write, and speak English fluently
- •Participant must have a smartphone and be able to download and use the App
- •Participant must have an established primary care provider
- •Participant must be willing and able to consume study supplements throughout the duration of study period
排除标准
- •History or presence of cancer in the prior 2 years, except for non-melanoma skin cancer.
- •Known immune system issues or immunodeficiency disease
- •History of viral illness which could be reactivated by immune downregulation
- •Presence of clinically significant acute or unstable cardiovascular and cerebrovascular (stroke) disease
- •Diagnosis of a transient ischemic attack in the 6 months prior to screening
- •Participants infected with hepatitis C or HIV
- •Presence of active infection in previous 4 weeks
- •Any other illness, psychiatric disorder, alcohol or chemical dependence that in the opinion of the Clinical Investigator would render a participant unsuitable to participate in the study
- •Unable or unwilling to provide required blood sample for testing
- •Current or previous use of known prescription immunomodulating products (e.g. glucocorticoids, TNF-alpha inhibitors) in the month prior to the start of the trial.
- •A known history of blood dyscrasias including coagulopathy
- •Any person deemed by the Investigator as having a low likelihood of complying with study protocol (e.g. evidence of history of non-compliance, history of poor follow-up, multiple or complex scheduling conflicts).
- •Planned surgical procedure during study period
- •Participants who are actively engaged in a weight loss program or have started any new medications during the duration of the trial that can potentially interfere with the study, as deemed appropriate by Principal Investigator.
研究组 & 干预措施
SRW Cel system
Cel1, Cel2, Cel3
Patients will take all three supplements once daily. Patients will take 2 capsules of each supplement in the morning with food.
干预措施: SRW Cel System (Dietary Supplement)
结局指标
主要结局
Biological age
时间窗: Change in epigenetic age from baseline to 12 months
The primary outcome measure for the study is biological age, measured by DNA methylation, using blood and saliva samples collected from patients.
次要结局
- C-reactive protein(Change in inflammatory marker from baseline to 12 months)
- Inflammatory marker IL-6(Change in inflammatory marker from baseline to 12 months)